Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

Full Title: 
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
Author(s): 
Rashi J
Alobaida A
Al-Hilal TA
Hammouda S
McMurtry IF
Nozik-Grayck E
Stenmark KR
Ahsan F
Journal: 
Journal of Controlled Release
Applications: 
Subject: 
Referenced Products: 
SPR-868
Keywords: 
Pulmonary arterial hypertension
PPAR-γ
Rosiglitazone
PLGA particles
Inhalational delivery
Summary: 
Fle Heading / Physical Location: 
Publication date (ref): 
June 2018